marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2022-Q2
hinzugefügt 15.08.2022
Allena Pharmaceuticals Kennzahlen 2011-2024 | ALNA
Kennzahlen Jährlich Allena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -2.2 | -1.3 | -4.4 | -1.9 | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.7 | -1.0 | -2.1 | -1.7 | -4.8 | -18.4 | -11.3 | - | - | - | - |
EV (Enterprise Value) |
-14.1 M | 52.7 M | 46.1 M | 111 M | -40.5 M | 83.5 M | 105 M | - | - | - | - |
EBITDA per Share |
-0.696 | -0.758 | -2.11 | -1.71 | -4.62 | - | - | - | - | - | - |
EV/EBITDA |
0.3 | -1.6 | -0.8 | -2.9 | 2.1 | - | - | - | - | - | - |
PEG |
- | -0.07 | 0.05 | -0.07 | 0.01 | - | - | - | - | - | - |
P/B |
- | 3.2 | 3.4 | 3.2 | 0.5 | - | - | - | - | - | - |
P/CF |
- | -2.5 | -1.4 | -4.9 | -1.9 | - | - | - | - | - | - |
ROE % |
-257.91 | -145.53 | -275.26 | -72.08 | -26.13 | - | - | - | - | - | - |
ROA % |
-140.01 | -84.37 | -138.79 | -54.65 | -22.49 | - | - | - | - | - | - |
ROCE % |
-252.54 | -97.49 | -202.24 | -59.85 | -23.62 | - | - | - | - | - | - |
Current Ratio |
2.2 | 6.1 | 3.0 | 11.2 | 12.7 | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Allena Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | -0.08 | -0.13 | -0.13 | -0.17 | -0.24 | -0.21 | -0.24 | -0.22 | -0.26 | -0.31 | -0.47 | -0.57 | -0.54 | -0.55 | -0.46 | -0.46 | -0.42 | -0.38 | -0.48 | -3.49 | -3.46 | -4.24 | -4.65 | -4.59 | -5.26 | -3.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.07 | -0.13 | -0.12 | -0.16 | -0.23 | -0.21 | -0.2 | -0.21 | -0.24 | -0.3 | -0.46 | -0.56 | -0.54 | -0.55 | -0.47 | -0.47 | -0.39 | -0.38 | -0.32 | -3.21 | -3.31 | -4.12 | -4.47 | -4.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-552.64 | -382.09 | -430.85 | -319.28 | -267.09 | -257.62 | -244.42 | -161.43 | -145.53 | -166.13 | -207.83 | -242.47 | -275.26 | -228.64 | -170.61 | -122.54 | -72.08 | -60.70 | -47.11 | -35.22 | -26.13 | -7.58 | 8.41 | 14.00 | 20.84 | 10.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-149.07 | -131.53 | -160.46 | -159.24 | -133.63 | -130.16 | -121.85 | -93.63 | -84.37 | -91.32 | -109.66 | -124.80 | -138.79 | -120.22 | -95.84 | -76.05 | -54.65 | -46.85 | -37.13 | -28.68 | -22.49 | -28.13 | -35.67 | -30.86 | -24.97 | -12.40 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-469.66 | -338.22 | -385.97 | -312.47 | -261.52 | -252.12 | -239.45 | -156.93 | -141.73 | -163.15 | -205.62 | -242.47 | -276.34 | -230.45 | -172.52 | -123.06 | -71.97 | -60.12 | -45.76 | -34.71 | -25.28 | -7.23 | 8.33 | 13.73 | 20.42 | 10.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | 1.3 | 2.1 | 2.2 | 2.5 | 1.7 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.0 | 2.0 | 2.0 | 2.0 | 4.1 | 4.1 | 4.1 | 4.1 | 7.2 | 7.2 | 7.2 | 7.2 | 3.8 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung